The Depo-Provera (depo-medroxyprogesterone acetate, or DMPA) injectable contraceptive has been recently linked to invasive breast cancer. A first-of-its kind, large-scale, U.S. study reveals a potential association between Depo-Provera and breast cancer in young women who used the injectable birth control method within five years and for at least one year. The Depo-Provera injury lawyers at Parker Waichman, LLP are currently investigating potential lawsuits on behalf of people who have suffered life-threatening side effects following use of Depo-Provera, such as invasive breast cancer.
Depo-Provera contains the same progestin found in the controversial hormone therapy Prempro, which has been linked to increased risks of breast cancer in postmenopausal women. While evidence links the progestin in Depo-Provera and Prempro to breast cancer, only a few studies have assessed the breast cancer risk in young women who take DMPA, and those results have been mixed. If you suffered a serious Depo-Provera injury, such as breast cancer, you may be eligible to obtain compensation through a lawsuit. Our Depo-Provera lawyers are currently offering free lawsuit evaluations to anyone injured by DMPA. To learn more about filing a Depo-Provera lawsuit, we urge you to contact us today.
Depo-Provera, or DMPA, a progestin-only contraceptive shot, is administered for the prevention of ovulation. Every shot provides pregnancy protection for up to 14 weeks; however, the injection must be administered once every 12 weeks to achieve full protection.
This month, results of a large-scale study revealing potential links between Depo-Provera and breast cancer, were published in the journal, Cancer Research. The study compared data on 1,028 Seattle-area women ages 20 – 44 with a breast cancer diagnosis to 919 age-matched controls with no breast cancer history. The research revealed that about 10 percent of the women used Depo-Provera and that about 3.1% of the women who received a diagnosis of breast cancer had used Depo-Provera for at least 12 months in the prior five years, versus 1.6 percent in the control group. The women in the group who had most recently used Depo-Provera for at least one year experienced a 2.2-fold increased risk of developing invasive breast cancer.
Breast cancer epidemiologist, Christopher I. Li, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center who led the research pointed out that “Our study adds to the body of knowledge from international studies conducted in a diverse group of countries—Kenya, New Zealand, Thailand, Mexico and Costa Rica—which have shown that one of the risks associated with DMPA use may be an increased risk of breast cancer.” Although breast cancer in younger women is relatively rare, the researchers noted that their “findings emphasize the importance of identifying the potential risks associated with specific forms of contraceptives, given the number of available alternatives.”
Legal Help for Victims of Depo-Provera Injuries
Parker Waichman LLP is one of the preeminent personal injury law firms in the US. Parker Waichman LLP is listed in Best Lawyers, the oldest and most respected peer-review publication in the legal profession. The attorneys of Parker Waichman LLP are also the authors of “Personal Injury Law for Dummies,” an easy-to-understand guide to all aspects of personal injury law.
If you or a love one suffered a serious adverse reaction, such as invasive breast cancer, following use of Depo-Provera injectable birth control, you may be entitled to receive compensation for medical bills, lost wages, pain and suffering, and other damages by filing a Depo-Provera lawsuit. To discuss your case with one of our Depo-Provera injury lawyers, please fill out our online form or call 1-800 LAW INFO (1-800-529-4636) today.